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Abstract 
Objectives: To analyze nationwide information on the timing of surgical procedures, 
cost of surgery, hospital length of stay following surgery and surgical complications of 
female genital restoration surgery (FGRS) in females with congenital adrenal 
hyperplasia (CAH). 
Methods: We used the Pediatric Health Information System database to identify 
patients with CAH who underwent their initial FGRS in 2004-2014. These patients were 
identified by an ICD-9 diagnosis code for adrenogenital disorders (255.2) in addition to a 
vaginal ICD-9 procedure code (70.x, excluding vaginoscopy only) or perineal ICD-9 
procedure code (71.x), which includes clitoral operations (71.4). 
Results: 544 (11.8%) females underwent FGRS between 2004 and 2014. Median age 
at initial surgery was 9.9 months (interquartile range 6.8 – 19.1 months). 92% 
underwent a vaginal procedure, 48% underwent a clitoral procedure, and 85% 
underwent a perineal procedure (non-clitoral). The mean length of stay was 2.5 days 
(standard deviation 2.5 days). The mean cost of care was $12,258 (median $9,558). 30-
day readmission rate was 13.8%. 2.0% underwent reoperation before discharge, and 
one (0.2%) was readmitted for a reoperation within 30 days. 4.0% had a perioperative 
surgical complication.  
Conclusions: Overall, 12% of girls with CAH underwent FGRS at one of a national 
collaborative of freestanding children’s hospitals. The majority underwent a vaginoplasty 
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as a part of their initial FGRS for CAH. Clitoroplasty was performed on less than half the 
patients. Overall, FGRS for CAH is performed at a median age of 10 months and has 
low 30-day complication and immediate reoperation rates. 
 
Introduction:  
 
Congenital adrenal hyperplasia (CAH) results in genital virilization in female patients. 
Many parents still opt to proceed with female genital restoration surgery (FGRS: 
clitoroplasty, labiaplasty with or without vaginoplasty) early in life, despite recent 
controversies[1]. 
 
When surveyed, the majority of surgeons perform early vaginoplasty[4], and the majority 
of patients with CAH and their parents prefer early FGRS [6,7,10]. Available analyses of 
nationwide databases (Pediatric Health Information System [PHIS], Faculty Practice 
Solutions Center Database) demonstrates that 78-89% surgeries performed for virilized 
genitalia on CAH patients <2 years of age included vaginoplasty[17]. 
 
We hypothesize that the majority of FGRS are performed prior to 12 months of age. We 
sought to determine the timing of FGRS in patients with CAH using administrative data 
from a national collaborative of freestanding pediatric hospitals. Additionally, we 
analyzed the changes over the past ten years, cost of surgery, admission length, 
reoperations, and complications. The intentions of this study were to establish the age 
at which surgery is done, the components of the surgeries performed, the cost, surgical 
complication rate and the changes that have occurred over the 10 years data were 
analyzed. 
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Materials & Methods:  
 
Data for this study were obtained from PHIS, an administrative database that contains 
inpatient, emergency department, ambulatory surgery, and observation data from 43 
not-for-profit, tertiary care pediatric hospitals in the United States. Included hospitals are 
affiliated with the Children’s Hospital Association, a business alliance of children’s 
hospitals. Data quality and reliability are assured through a joint effort between the Child 
Health Corporation of America and participating hospitals. The data warehouse function 
for the PHIS database is managed by Thomas Reuters (Ann Arbor, MI). For the 
purposes of external benchmarking, participating hospitals provided 
discharge/encounter data, including demographics, diagnoses, and procedures. Forty-
two of these hospitals also submit resource utilization data (e.g. pharmaceuticals, 
imaging, and laboratory) into PHIS. Data were de-identified at the time of data 
submission and subjected to a number of reliability and validity checks before being 
included in the database.  
 
We used PHIS to identify patients with CAH who underwent their initial FGRS between 
2004 (the first year when data were available in PHIS) and 2014. We defined our cohort 
with the following characteristics: 1) born after 2004 (in order to only obtain patients’ 
initial surgery after birth), 2) had an ICD-9 diagnosis code for adrenogenital disorders 
(255.2), and 3) a vaginal ICD-9 procedure code (70.x) or perineal ICD-9 procedure code 
(71.x).   
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Common vaginal procedure codes include: vaginoscopy (70.21), vaginal reconstruction 
(70.62), and other repair of vagina (70.79). Common perineal procedure codes 
included: operations on the clitoris (71.4), other repair of vulva and perineum (71.79), 
other operations on the vulva (71.8), and other operations on female genital organs 
(71.9).  Perineal procedures were defined as any perineal ICD-9 procedure code 71.x, 
excluding operations on the clitoris (71.4), which was defined as a clitoral procedure. 
We excluded patients who underwent vaginoscopy alone.  
 
We abstracted the age at the initial operation, procedure performed (by ICD-9 
procedure codes), length of stay, ratio of charge-to-cost (RCC) based cost of each 
encounter, readmission within 30 days, reoperation before discharge, reoperation within 
30 days, and perioperative surgical complications. Analysis for duplicates was 
performed to identify reoperations. We were not able to assess outpatient follow-up, as 
outpatient visits are not consistently found in PHIS. We did not assess for long term 
repeat or redo procedures, i.e., redo vaginoplasties, due to the relatively short window 
of follow up in the PHIS cohort.  
 
High-volume centers were defined arbitrarily as centers that performed >30 procedures 
within the 10-year period, which included 3 hospitals accounting for >30% of the cases. 
Medium-volume centers performed 10-30, and low-volume centers performed <10 
procedures (<1 procedure/year). 
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We used the McNemar’s chi-squared test to examine the change in procedure type over 
time by comparing the procedural rates in 2004 to the procedural rates in 2014. We 
performed mixed effects multiple regression (with hospital as a random effect) when 
determining association between subject demographics (age, hospital volume, ethnicity, 
race, insurance type) and procedure type, cost, and length of stay. All analyses were 
completed using the R software package (www.r-project.org).  The Institutional Review 
Board at Indiana University approved this study with exempt status prior to data 
acquisition or analysis. 
 
 
Results: 
 
Our query yielded 544 patients who underwent FGRS between 2004-2014 (Figure 1, 
Table 1). During this time frame, there are 15,497 encounters captured in PHIS for 
6,886 unique patients with 4,617 unique females with CAH. With an annual incidence of 
1/5,000 - 1/15,000[18] and an annual birthrate of approximately 4,000,000[19], there 
was an estimated 2,933-8,800 patients born during the study period, indicating 78.3%-
100% of patients were captured. Median age at initial surgery was 9.9 months 
(interquartile range 6.8–19.1 months). There was only one spike in the frequency of 
surgeries performed at around the age of 10 months (Figure 2). 
 
During the initial FGRS in this cohort, 92.3% underwent a vaginal procedure, 48.3% 
underwent a clitoral procedure, and 85.3% underwent a perineal procedure (excluding 
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ICD-9 code 71.4 clitoral procedures).  Clitoroplasty varied by hospital volume; high-
volume centers performed clitoroplasty 26.7% of the time, while medium- and low-
volume centers performed clitoroplasty 56.3% and 60.6% of the time, respectively. 
  
From 2004 to 2014, there was a small change in the type of procedure performed 
(Figure 3). The change in percentage of procedures over time was a mean -1.8% per 
year for vaginal procedures alone, mean +2.2% per year for vaginal and clitoral 
procedures, and a mean -0.2% per year for procedures without vaginal procedures, with 
a significant difference between vaginal alone vs. vaginal and clitoral procedures 
(p=0.01). There was no difference between vaginal alone versus perineal/clitoral 
procedures alone (p=0.94). Therefore, over the past ten years, there has been an 
increase in the proportion of combination procedure and a decrease in the proportion of 
vaginal only procedures during initial FGRS, although the shift was relatively small. 
 
Three high-volume centers (centers which performed >30 cases over the ten year 
period) performed 165/544 procedures (30.3%) (Supplementary Figure 1). 
 
The mean length of stay was 2.5 days (standard deviation 2.5 days). Length of stay was 
longer in high-volume center: mean 4.3 days, median 4 days (high) vs. 2.4 days, 2 days 
(medium) vs. 2.4 days, 2 days (low). 
  
The average RCC-based cost of care was $12,258 (median $9,558). On multivariate 
regression, high-volume centers had a significantly higher cost of care (defined as a 
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binary variable of >$10,000) compared to low- (OR 0.31, p<0.05) and medium-volume 
centers (OR 0.21, p<0.05). High-volume centers demonstrated higher unit/room cost: 
$14,889.99 (high) vs. $6,266.79 (medium) vs. $6,520.19 (low). Operating room costs 
were comparable between centers: $19,927.50 (high) vs. $20,963.71 (medium) vs. 
$18,032.22 (low) (Supplementary Figure 2). 
 
Only surgical complications and re-admissions could be considered and “medical” 
complications were not recorded. Readmission for any reason within 30 days occurred 
in 75 of 544 subjects (13.8%). On multivariate regression, there was no significant 
difference between readmission rates in low- (OR 1.99, p=0.09) and medium-volume 
centers (OR 1.95, p=0.06) compared to high-volume centers. Of those who were 
readmitted to an inpatient service, the most common admission diagnoses were:  CAH 
(255.2 and 752.49, 21.3%), surgical complication or hemorrhage (998.32, E8788, 
959.14, 998.11, V4589, 16.0%), infectious enteritis or gastroenteritis (558.9, 787.03, 
86.2, 88.0, 10.7%), and UTI (599.0, 5.3%). 
 
Eleven patients (2.0%) underwent a reoperation before discharge. The ICD-9 procedure 
codes for these reoperations included: other repair of vagina (70.79, n=7), other 
cystoscopy (57.32, n=2), vaginoscopy (70.21, n=1), and dilation of anal sphincter 
(96.23, n=1). One patient (0.2%) was readmitted for a reoperation within 30 days: other 
cystoscopy (57.32) with other repair of vagina (70.79).  
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Using the standard PHIS database methodology, any ICD-9 code associated with a 
surgical complication was flagged. Twenty-two patients (4.0%) were recorded as having 
a perioperative surgical complication, but our data set did not indicate the type of 
complication.  
  
 
Comment: 
 
This study represents a large sample of the current practice patterns for initial FGRS in 
patients with CAH at United States’ pediatric hospitals. Initial FGRS in CAH patients 
continues to occur at a young age of 10 months, with a 30-day complication rate of 
13.8% and rare immediate reoperation rate (2.0%). It appears that the majority of 
patients undergo vaginoplasty during their initial reconstructive surgery. While 
information obtained from this study is valuable in providing evidence of current practice 
in the units reviewed, it does not provide evidence of surgical or psychological 
outcomes.  
 
Outcomes in vaginoplasty are difficult to evaluate as the exact surgical technique, 
patient compliance of steroid replacement, and the initial degree of virilization (Prader 
score) is seldom reported. Published poor outcomes in vaginoplasty may reflect 
outdated surgical technique (e.g Fortunoff flap for high confluence urogenital sinuses) or 
technical error (inadequate vascular supply, inexperienced surgeons). Multiple reports 
have recommended patients be tretated at a center of excellence[20-22]. Less than half 
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of patients underwent clitoroplasty at their initial surgery, likely reflecting a variety of 
Prader stages at presentation and current controversies regarding clitoral 
surgery{Hughes:2006js, Hughes:2006dd, Mouriquand:2016cj}. 
 
Although there is controversy in the CAH literature regarding both the timing of the initial 
FGRS and what components of FGRS are performed with initial surgery, there is 
minimal data on current trends of practices at United States hospitals. In a survey of 61 
surgeons (of which 12% were based in the United States), Yankovic et al. reported that 
75% perform a combined procedure of clitoroplasty, labiaplasty and vaginoplasty 
whereas 8% perform vaginoplasty alone for CAH[4]. The majority of respondents (72%) 
supported surgery in the first 2 years of life and 8% advocated for late surgery. Of those 
who supported early surgery, 68% would perform all components of reconstruction at 
the same time and 43% would delay some components. In comparison, our study 
demonstrated that in the United States, 92% of patients with CAH underwent a vaginal 
procedure, 48% underwent a clitoral procedure, 85% underwent a perineal procedure. 
The majority of patients underwent surgery at a young age (10 months). We presume 
that if a clitoroplasty was not necessary due to lower Prader grade (I/II) or a less 
prominent clitoris, a surgeon may advise a family to not proceed with this aspect of the 
FGRS. Other reasons for lower incidence of clitoroplasty would include potential 
miscoding, or a potential recent movement towards delaying clitoroplasty to the age of 
consent. Low- and medium-volume centers performed clitoroplasty at a higher rate. The 
reasons for this are unclear. 
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A recent paper that analyzed females with CAH seen at 60 institutions using the Faculty 
Practice Solutions Center database, demonstrated that the median age for combined 
clitoroplasty/vaginoplasty was 11.3 months, while median ages for vaginoplasty alone 
was 53 months and for clitoroplasty alone was 70 months, with histograms for both 
demonstrating a second peak at adolescence[17]. This study included 577 female 
patients with CAH (<12 months of age) seen between 2009 and 2011 and 18% 
underwent feminizing surgery. 
 
Our analysis utilized a cohort of children from large American tertiary children’s 
hospitals to focus on the current practice of primary FGRS and perioperative outcomes 
of this initial operation.  We found a vaginoplasty rate of 92%, was similar to the 
previously reported 89% vaginoplasty rate for those who were operated on children at 
<2 years of age; however, they found a higher rate of clitoroplasty (73% vs. our 
48%)[17]. While our study corroborates the previously reported vaginoplasty rate, the 
reason behind the differences between studies is unclear. It may be due to coding or 
hospital practice differences between PHIS hospitals and those in the Faculty Practice 
Solutions Center database. Additionally, this could be due to the differences in number 
of patients captured, as this study captured 4,617 females while the Sturm et al. study 
captured 2,614 females with CAH. Interestingly, in following their cohort of those 
patients who presented at less than 12 months of age, only 18% proceeded with 
surgery within 1-4 years of follow-up. This may reflect the wide anatomical spectrum 
observed in females with CAH.  
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In our analysis, 3 hospitals were responsible for 30% of all surgeries and averaged >3 
CAH surgeries per year. This seems to demonstrate a regionalization of CAH surgery to 
specific centers. Additionally, we demonstrate that high-volume centers had a longer 
length of stay, reflected in a higher cost to the hospital and higher room/unit costs to 
patients. This may reflect a higher medical complexity of patients referred to these high-
volume centers.  Differences in cost could also be related to variation in practice 
between centers, cost variation based on hospital rather than patient factors, or referral 
bias stemming from the concentration of more complex reconstruction being performed 
by a few highly-experienced surgeons. 
 
The limitations of our study include the reliance on administrative data to identify cases 
of FGRS. Errors in billing and coding may have affected the number of cases and the 
cost data available. Additionally, given the low use of CPT codes in PHIS, ICD-9 codes 
were used, and may not properly capture the procedures performed or perioperative 
complications encountered. As only surgical complications and re-admissions were 
considered, the complication rate may be underestimated. Further, the inability to pull 
clinical details, such as level of virilization, affects interpretation of case complexity. 
Lastly, our data analysis is limited to a subset of free-standing pediatric hospitals, so 
data may not fully reflect national trends. Another limitation is that the study only 
includes PHIS institutions and may have missed some patients, however, our data likely 
captured 78.3-100% of patients with CAH. In addition, our dataset does not include 
patients who have either decided to delay or forego reconstruction, thus conclusions 
about age at surgery must be tempered. 
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This study was designed to describe current FGRS practice in CAH patients in the 
United States.  While the surgeries observed were performed on a large majority of 
children, this is not evidence that it is correct and should not be taken as such. Should 
the recommendations of the Chicago consensus{Hughes:2006js, Hughes:2006dd} and 
more recent recommendations{Mouriquand:2016cj} be more closely followed and 
surgery after puberty become more desirable, attention must be focused on how to train 
a cadre of surgeons to be able to perform FGRS following puberty as this does not exist 
in large numbers at present. As is being done increasingly in health systems in other 
developed nations like the UK, rare surgeries such as these should be referred to 
centers of excellence for optimal patient outcomes.   
 
Conclusions: 
 
The majority of patients undergoing treatment at one of a national collaborative of 
freestanding children’s hospitals underwent a vaginoplasty as a part of their initial FGRS 
for CAH. Clitoroplasty was performed on less than half the patients. Overall, FGRS for 
CAH is performed at a median age of 10 months and has low 30-day complications and 
immediate reoperation rates. 
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Figure Legend:  
 
Figure 1. Subject Selection Strategy. 
 
Figure 2. Frequency of Procedure by Age 
 
Figure 3. Change Over Time in Procedure Type (2004-2014) 
 
Supplementary Figure 1. Number of Cases by Hospital 
 
Supplementary Figure 2. Proportion of Charges, by Category in High-, Medium- and 
Low-Volume Centers. 
 
Table 1 Subject Demographics 
Patients in cohort N=544 
Median age at initial surgery (IQR) 9.9 months (6.8 – 19.1) 
Care at high-volume center 165 (30.3%) 
Care at medium-volume center 252 (46.3%) 
Care at low-volume center 127 (23.3%) 
Type of FGRS Performed  
Vaginoplasty only 73 (13.4%) 
Perineoplasty only 38 (7.0%) 
Clitoroplasty only 0 (0%) 
Vaginoplasty and perineoplasty 170 (31.3%) 
Vaginoplasty and clitoroplasty 7 (1.3%) 
Perineoplasty and clitoroplasty 4 (0.7%) 
Vaginoplasty, perineoplasty, 
clitoroplasty 
252 (46.3%) 
Total patients who underwent 
vaginoplasty 
502 (92.3%) 
Total patients who underwent 464 (85.3%) 
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perineoplasty 
Total patients who underwent 
clitoroplasty 
263 (48.3%) 
Average length of stay (sd) 2.5 days (2.5) 
Average RCC-based cost (median) $12,258 ($9,558) 
Readmissions within 30 days 75 (13.8%) 
Reoperation rate prior to discharge 11 (2.0%) 
ICD-9 other repair of vagina 7 (63.6%) 
ICD-9 cystoscopy 2 (18.2%) 
ICD-9 vaginoscopy 1 (9.1%) 
ICD-9 dilation of anal sphincter 1 (9.1%) 
Reoperation rate within 30 days of 
discharge 
1 (0.2%) 
Postoperative surgical complication 22 (4.0%) 
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